BBGBloomberg·2hBusiness
score+0.50
Novartis Inks Chinese mRNA-Therapy Deal for Up to $7.8 Billion
Original
Novartis Inks Chinese mRNA-Therapy Deal for Up to $7.8 Billion
“The headline frames a substantial financial investment in medical innovation, signaling confidence in the therapy's potential and commercial viability.”